NCT00972140View on ClinicalTrials.gov

Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

October 31, 2006

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Formoterol

Formoterol-HFA pMDI 12µg twice daily

DRUG

Formoterol

Formoterol-DPI 12 µg twice daily

Trial Locations (1)

91-520

Prof. Iwona Graelewska Rzymowska, Lodz

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT00972140 - Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients | Biotech Hunter | Biotech Hunter